You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Acute lymphoblastic leukemia (ALL)/lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

Not yet recruiting
  • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
  • CD7-CART01
  • (no location specified)
Sep 26, 2023

B-Cell Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Trial in Tampa (Tecartus)

Recruiting
  • B-Cell Lymphoblastic Leukemia
  • Acute Lymphoblastic Leukemia
  • Tampa, Florida
    Moffitt Cancer Center
Nov 28, 2023

B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • HY004
  • +2 more
  • (no location specified)
Aug 18, 2023

Lymphoblastic Lymphoma, T-Cell Lymphoblastic Leukemia/Lymphoma, Lymphoblastic Leukemia Trial in Philadelphia (BEAM-201)

Recruiting
  • Lymphoblastic Lymphoma
  • +2 more
  • BEAM-201
  • Philadelphia, Pennsylvania
    Children's Hospital of Philadelphia
Jun 2, 2023

B Precursor Acute Lymphoblastic Leukemia, Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia Trial (Blinatumomab)

Not yet recruiting
  • B Precursor Acute Lymphoblastic Leukemia
  • Relapsed/Refractory B Precursor Acute Lymphoblastic Leukemia
  • (no location specified)
Sep 25, 2023

Pediatric Acute Lymphoblastic Leukemia, Leukemia, Acute Lymphoblastic Leukemia Trial in Boston (Sleep ALL Night)

Not yet recruiting
  • Pediatric Acute Lymphoblastic Leukemia
  • +2 more
  • Sleep ALL Night
  • Boston, Massachusetts
  • +1 more
May 10, 2023

T-cell Acute Lymphoblastic Leukemia, Lymphoblastic T-Cell Lymphoma Trial in Barcelona (CD1a-CAR T)

Not yet recruiting
  • T-cell Acute Lymphoblastic Leukemia
  • Lymphoblastic T-Cell Lymphoma
  • CD1a-CAR T
  • Barcelona, Spain
  • +1 more
Jan 10, 2023

B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • +2 more
  • Azacitidine Injection
  • +2 more
  • (no location specified)
Oct 15, 2023

B-cell Acute Lymphoblastic Leukemia Trial (CD19-CAR_Lenti_ALLO)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • (no location specified)
Oct 10, 2023

B-cell Acute Lymphoblastic Leukemia Trial in Hefei (QH103 Cell Injection, Fludarabine, Cyclophosphamide)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • QH103 Cell Injection
  • +2 more
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Sep 21, 2023

Infective Complications and Outcome of ALL Treated With INO

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +4 more
    • (no location specified)
    Aug 29, 2023

    T-cell Acute Lymphoblastic Leukemia/Lymphoma Trial in Beijing (Senl-T7)

    Recruiting
    • T-cell Acute Lymphoblastic Leukemia/Lymphoma
    • Senl-T7
    • Beijing, Hebei, China
      Hebei yanda Hospital
    Nov 22, 2022

    Acute Lymphoblastic Leukemia Trial in New York (Venetoclax)

    Recruiting
    • Acute Lymphoblastic Leukemia
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Feb 2, 2023

    MRD Detection by NGS in Pediatric B-ALL

    Completed
    • Acute Lymphoblastic Leukemia, Pediatric, Next Generation Sequencing
    • MRD
    • Hangzhou, Zhejiang, China
      The Children's Hospital of Zhejiang University School of Medicin
    Jul 25, 2023

    Acute Lymphoblastic Leukemia, Hodgkin Disease, Allogeneic Stem Cell Transplantation Trial in Erlangen (Low-field magnetic

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +2 more
    • Low-field magnetic resonance imaging
    • +3 more
    • Erlangen, Bavaria, Germany
      Department of Pediatrics and Adolescent Medicine
    Oct 23, 2023

    Acute Lymphoblastic Leukemia, in Relapse, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Columbus

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, in Relapse
    • +5 more
    • CD19 specific Chimeric Antigen Receptor T Cell
    • Columbus, Ohio
      Nationwide Children's Hospital
    Mar 9, 2023

    Leukemia, Acute Lymphoblastic Leukemia Trial in New York (gene-modified T cells targeted)

    Active, not recruiting
    • Leukemia
    • Acute Lymphoblastic Leukemia
    • gene-modified T cells targeted
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Feb 1, 2023

    Next-generation Sequencing in Pediatric B-ALL Children Patients

    Not yet recruiting
    • Acute Lymphoblastic Leukemia, Pediatric
    • (no location specified)
    Apr 19, 2023

    Acute Lymphoblastic Leukemia Trial (inotuzumab ozogamicin)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • inotuzumab ozogamicin
    • (no location specified)
    Jan 6, 2023

    B-cell Acute Lymphoblastic Leukemia Trial (single dose of CNCT19)

    Not yet recruiting
    • B-cell Acute Lymphoblastic Leukemia
    • single dose of CNCT19
    • (no location specified)
    Dec 19, 2022

    Cytarabine+Thiotepa + Fludarabine + Busulfan, T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial in Hangzhou

    Recruiting
    • Cytarabine+Thiotepa + Fludarabine + Busulfan
    • T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
    • cytarabine+thiotepa+ fludarabine + busulfan
    • Hangzhou, China
      The First Affiliated Hospital, College of Medicine, Zhejiang Uni
    Oct 26, 2022

    CAR, Refractory Acute Lymphoblastic Leukemia, Relapsed Adult ALL Trial in Suzhou (Treatment)

    Recruiting
    • CAR
    • +2 more
    • Suzhou, Jiangsu, China
      The First Affiliated Hospital of Soochow University
    Dec 27, 2022

    B-cell Acute Lymphoblastic Leukemia, B-ALL Trial in Kunming (U-CAR-T Cells (LstCAR019))

    Withdrawn
    • B-cell Acute Lymphoblastic Leukemia
    • B-ALL
    • U-CAR-T Cells (LstCAR019)
    • Kunming, Yunnan, China
      Kunming Hope of Health Hospital
    Nov 27, 2022

    Patients Who Received Inotuzumab Ozogamicin for B-cell ALL That

    Not yet recruiting
    • Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
    • Inotuzumab Ozogamicin
    • (no location specified)
    Nov 3, 2022

    Acute Lymphoblastic Leukemia (ALL) Trial (Nilotinib)

    No longer available
    • Acute Lymphoblastic Leukemia (ALL)
    • (no location specified)
    Aug 5, 2022